Onconova Therapeutics, Inc. (NASDAQ:NASDAQ:ONTX) Q2 2022 Earnings Conference Call August 11, 2022 16:30 ET Company Participants Bruce Mackle - Investor Relations, LifeSci Advisors Steve.
In a study recently published in Cancer Research, a journal of the American Association for Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center School of Medicine Cancer Center, sought to expand upon his lab's previous research that showed ALT tumors identified by a biomarker known as C-circles share a common biology that confers vulnerabilities to be exploited for cancer therapy.
Research finds, exploits vulnerability in certain high-risk cancers miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.